Skip to content

Welpharma: what changed

BE 0661.922.258NACE 64.210, Activities of holding companiesOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€203,418
2024 · €216,955-€13,537
Equity
€1.4m
2024 · €1.2m+€203,418
Cash
€32,120
2024 · €46,175-€14,055
Balance sheet total
€2.7m
2024 · €2.6m+€59,747

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€90,148

    up €90,148 (+218%), from €41,274 to €131,422

    of which Other amounts receivable: +€92,686

Equity and liabilities
  • Reserves +€203,418

    up €203,418 (+24.5%), from €829,802 to €1.0m

  • Debts after one year -€148,821

    down €148,821 (-14.4%), from €1.0m to €881,352

Income statement
  • Gross operating margin -€20,948

    down €20,948 (-5.8%), from €361,593 to €340,645

  • Taxes -€4,702

    down €4,702 (-4.9%), from €95,835 to €91,134

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €216,955
Gross operating margin -€20,948
Depreciation +€349
Other operating charges -€520
Financial charges +€2,879
Taxes +€4,702
Result 2025 €203,418
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€149,642
Investment -€3,939
Financing -€159,758
Cash 2024 €46,175
Net result for the year +€203,418
Depreciation +€21,136
Receivables within one year -€90,148
Deferred charges and accrued income -€852
Trade debts -€5,678
Tax, wage and social debts +€1,100
Other debts +€21,386
Accrued charges and deferred income -€722
Investment in fixed assets (net) -€3,939
Debts after one year -€148,821
Current portion of long-term debt -€10,937
Cash 2025 €32,120
brings cash intakes cash out
Every line side by side 41 lines
Line Code 2024 2025 Change %
Total assets 20/58 €2,606,082 €2,665,829 +€59,747 +2.3%
Fixed assets 21/28 €2,513,459 €2,496,262 -€17,197 -0.7%
Tangible fixed assets 22/27 €393,230 €376,032 -€17,197 -4.4%
Land and buildings 22 €360,324 €353,029 -€7,295 -2.0%
Plant, machinery and equipment 23 - €3,503 +€3,503
Furniture and vehicles 24 €32,906 €19,501 -€13,405 -40.7%
Financial fixed assets 28 €2,120,230 €2,120,230 = 0.0%
Current assets 29/58 €92,623 €169,567 +€76,944 +83.1%
Amounts receivable within one year 40/41 €41,274 €131,422 +€90,148 +218%
Trade receivables 40 €2,538 - -€2,538
Other amounts receivable 41 €38,736 €131,422 +€92,686 +239%
Cash at bank and in hand 54/58 €46,175 €32,120 -€14,055 -30.4%
Deferred charges and accrued income 490/1 €5,174 €6,025 +€852 +16.5%
Total equity and liabilities 10/49 €2,606,082 €2,665,829 +€59,747 +2.3%
Equity 10/15 €1,240,864 €1,444,282 +€203,418 +16.4%
Contributions 10/11 €100,000 €100,000 = 0.0%
Reserves 13 €829,802 €1,033,220 +€203,418 +24.5%
Distributable reserves 133 €829,802 €1,033,220 +€203,418 +24.5%
Profit (loss) carried forward 14 €311,063 €311,063 -€0 0.0%
Amounts payable 17/49 €1,365,218 €1,221,547 -€143,671 -10.5%
Amounts payable after more than one year 17 €1,030,173 €881,352 -€148,821 -14.4%
Financial debts 170/4 €1,030,173 €881,352 -€148,821 -14.4%
Amounts payable within one year 42/48 €324,127 €329,998 +€5,872 +1.8%
Current portion of amounts payable after more than one year 42 €159,758 €148,821 -€10,937 -6.8%
Trade debts 44 €6,627 €949 -€5,678 -85.7%
Suppliers 440/4 €6,627 €949 -€5,678 -85.7%
Taxes, remuneration and social security 45 €19,215 €20,315 +€1,100 +5.7%
Taxes 450/3 €19,215 €20,315 +€1,100 +5.7%
Other amounts payable 47/48 €138,526 €159,913 +€21,386 +15.4%
Accrued charges and deferred income 492/3 €10,919 €10,197 -€722 -6.6%
Non-recurring operating income 76A €5,000 - -€5,000
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €21,486 €21,136 -€349 -1.6%
Other operating charges 640/8 €1,750 €2,269 +€520 +29.7%
Gross operating margin 9900 €361,593 €340,645 -€20,948 -5.8%
Operating profit (loss) 9901 €338,358 €317,239 -€21,118 -6.2%
Financial charges 65/66B €25,567 €22,688 -€2,879 -11.3%
Recurring financial charges 65 €25,567 €22,688 -€2,879 -11.3%
Profit (loss) for the period before taxes 9903 €312,791 €294,552 -€18,239 -5.8%
Income taxes 67/77 €95,835 €91,134 -€4,702 -4.9%
Profit (loss) for the period 9904 €216,955 €203,418 -€13,537 -6.2%
Profit (loss) for the period to be appropriated 9905 €216,955 €203,418 -€13,537 -6.2%

Value

latest balance sheet 31-03-2025 · indication, not a valuation or advice

For holding and financial companies, the adjusted equity is usually a better measure than the earnings. Give the capitalised earnings a lower weight then.

Indicative value of the equity

Indication, not a valuation or advice
€1.3m to €1.5m

Midpoint €1.4m · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years, excluding non-recurring income and charges earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity €1.4m
Capitalised earnings €1.2m to €1.6m
Indication €1.3m to €1.5m

Adjusted equity

balance sheet 31-03-2025
Equity (10/15)
€1,444,282
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€1.4m

Capitalised earnings

net result for the year (9904)
2025
€203,418
2024
€216,955
excluding non-recurring income and charges
€211,955
2023
€71,990
excluding non-recurring income and charges
€71,415
2022
€375,905
2021
€108,946
Average result, excluding non-recurring income and charges
€162,263
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€1.2m / €1.4m / €1.6m

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 March 2024 and 31 March 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 18 November 2026 via checked.be.